ストックスクリーナーアプリを入手
3.70
1.93%
0.07
アフターアワーズ：
3.80
0.10
+2.70%
前日終値:
$3.63
開ける：
$3.73
24時間の取引高:
164.52K
Relative Volume:
0.73
時価総額：
$113.34M
収益：
$71.61M
当期純損益:
$-48.59M
株価収益率:
-2.1131
EPS:
-1.751
ネットキャッシュフロー:
$-32.88M
1週間 パフォーマンス:
-3.65%
1か月 パフォーマンス:
-26.44%
6か月 パフォーマンス:
-27.59%
1年 パフォーマンス:
-54.55%
1日の値動き範囲:
$3.69
$3.90
1週間の範囲:
$3.53
$4.08
52週間の値動き範囲:
$3.22
$10.29
Avita Medical Inc Stock (RCEL) Company Profile
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
3.70 | 111.19M | 71.61M | -48.59M | -32.88M | -1.751 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-05 | 開始されました | Northland Capital | Outperform |
| 2025-11-20 | アップグレード | BTIG Research | Sell → Neutral |
| 2025-08-08 | ダウングレード | BTIG Research | Neutral → Sell |
| 2024-12-24 | 開始されました | D. Boral Capital | Buy |
| 2024-04-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-06-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 開始されました | Piper Sandler | Overweight |
| 2020-08-27 | 開始されました | BofA Securities | Buy |
| 2020-04-21 | 開始されました | Oppenheimer | Outperform |
| 2020-03-03 | 開始されました | BTIG Research | Buy |
すべてを表示
Avita Medical Inc (RCEL) 最新ニュース
AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2025 earnings call transcript - MSN
AVITA Medical Inc at TD Cowen Healthcare Conference Transcript - gurufocus.com
Momentum Shift: Is AVITA Medical Inc stock a good dividend stockWeekly Volume Report & Weekly Top Performers Watchlists - baoquankhu1.vn
AVITA Medical (RCEL) Price Target Decreased by 14.77% to 7.65 - MSN
RCEL Stock Decline Viewed as a Buying Opportunity by Analysts - gurufocus.com
AVH Stock Price and Chart — ASX:AVH - TradingView
If You Invested $1,000 in Avita Medical Inc (RCEL) - Stock Titan
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
RCEL Stock Price, Quote & Chart | AVITA MEDICAL INC (NASDAQ:RCEL) - ChartMill
Avita Medical (RCEL) upgraded to buy: Here's what you should know - MSN
Will AVITA Medical Inc. stock recover after earningsDip Buying & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Insider Buying: David O'Toole Acquires Shares of AVITA Medical I - GuruFocus
AVITA Medical (RCEL) CFO adds 1,800 shares in open-market purchase - Stock Titan
Northland Securities Predicts Avita Medical Q1 Earnings - National Today
Growth Recap: Can AVITA Medical Inc maintain sales growthJuly 2025 Pullbacks & Verified Entry Point Signals - baoquankhu1.vn
Northland Capital Markets initiates coverage of AVITA Medical (RCEL) with outperform recommendation - MSN
AVITA Medical (RCEL) director Woody Fralin files initial Form 3 - Stock Titan
Avita Medical (NASDAQ:RCEL) Now Covered by Analysts at Northland Securities - MarketBeat
Avita Medical at TD Cowen Conference: Growth and Strategic Focus By Investing.com - Investing.com Canada
RCEL SEC FilingsAvita Medical Inc 10-K, 10-Q, 8-K Forms - Stock Titan
RCELAVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results - ADVFN Ltd
RCEL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Retail Trends: Can AVITA Medical Inc weather a recession2025 Trade Ideas & Reliable Momentum Entry Alerts - baoquankhu1.vn
Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade - Zacks Investment Research
Avita Medical Inc. (NASDAQ:RCEL) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Avita Medical Targets “Progressive” 2026 Growth, Guides $80M-$85M Revenue After Headwind Year - MarketBeat
Wall Street experts predict Avita Medical (RCEL) may surge by 29.87%: Here’s how you can approach trading - Bitget
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference - Investing News Network
Avita Medical (NASDAQ:RCEL) CFO David O'toole Purchases 3,000 Shares of Stock - MarketBeat
AVITA Medical (RCEL) CFO awarded RSU and stock option grants - Stock Titan
Avita Medical (RCEL) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Scar Treatment Market Size is Expected to Reach USD 56.30 Billion by 2033; Growth is Propelling Due to the Surging Awareness for Advanced Cosmetic and Reconstructive Procedures Globally - GlobeNewswire Inc.
AVITA Medical Inc Investor Webinar Transcript - gurufocus.com
RCEL: D. Boral Capital Maintains "Buy" Rating and $10 PT | RCEL Stock News - GuruFocus
Avita Medical (NASDAQ:RCEL) Earns "Buy" Rating from D. Boral Capital - MarketBeat
Broker tips 25% upside for this ASX healthcare stock following FY25 earnings results - MSN
Earnings call transcript: Avita Medical Q4 2025 sees steady revenue growth - Investing.com Nigeria
Avita Medical Earnings Call Signals Stabilizing Growth - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), American Well (AMWL) and Avita Medical (RCEL) - The Globe and Mail
Avita's Road to Profitability Is in Sight - Morningstar
AVITA Medical to Host Investor Webinar Briefing - Investing News Network
Ask AVITA Medical’s interim CEO your questions in Feb. 18 investor webinar Q&A - Stock Titan
Avita Medical Inc (RCEL) 財務データ
収益
当期純利益
現金流量
EPS
Avita Medical Inc (RCEL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| McNamara Robert | Director |
Aug 28 '25 |
Buy |
4.50 |
10,000 |
45,000 |
86,771 |
| O'Toole David D | CFO |
Aug 26 '25 |
Buy |
4.52 |
2,000 |
9,040 |
31,657 |
| McNamara Robert | Director |
Aug 19 '25 |
Buy |
5.00 |
10,000 |
50,000 |
76,771 |
| O'Toole David D | CFO |
Aug 12 '25 |
Buy |
4.81 |
2,000 |
9,620 |
29,657 |
2.03%
大文字化:
|
ボリューム (24 時間):